Group One Trading, L.P. Pliant Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 4,721 shares of PLRX stock, worth $7,742. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,721
Previous 10,509
55.08%
Holding current value
$7,742
Previous $138,000
95.65%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.84 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.86 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.47 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$5 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $79.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...